Register
for More
Information

Stay informed about CLN2 disease resources and information as it becomes available at: CLN2connection.eu

Register Now ›

New video
available!

Gail and Matthew Rich (UK) provide a personal insight into life with CLN2 disease and the impact it can have on children and their families.

Watch now! ›

The Natural Course of CLN2 Disease is Rapid

Children with CLN2 disease commonly experience a complete loss of cognitive abilities, motor function and vision within the first decade of life.1,2

See natural history data ›

Earlier Diagnosis is Critical & Testing is Straightforward

Given the rapid rate of progression, early diagnosis is essential to ensure that families can benefit from CLN2-specific management strategies and maximise quality time.3,4

Recognise early signs to shorten time to diagnosis ›

OPTIMISE CARE WITH CLN2 DISEASE MANAGEMENT STRATEGIES

Experts have identified CLN2 disease-specific management strategies that can greatly impact patient care and quality of life.4

View recommendations ›

References:
1. Schulz A et al. NCL diseases – clinical perspectives. Biochimica et Biophysica Acta. 2013;1832:1801-1806. 2. Mole SE and Williams RE. Neuronal ceroid-lipofuscinoses. 2001 Oct 10 [Updated 2013 Aug 1]. In: Pagon RA, Adam MP, Ardinger HH et al. eds. GeneReviews® [internet]. Seattle, WA: University of Washington; 1993-2016. 3. Nickel M et al. Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study. Lancet Child Adolesc Health 2018;2(8):582–590. 4. Williams RE et al. Management Strategies for CLN2 Disease. Pediatr Neurol 2017;69:102–112.